Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Nicholas, Salgia"'
Autor:
Marcin Kortylewski, Nazli Dizman, Nicholas Salgia, Marice Alcantara, Luis Meza, Sabrina Salgia, Jasnoor Malhotra, Paulo Bergerot, Nora Ruel, Ewa Karczewska
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Background Circulating cytokines and angiogenic factors have been associated with clinical outcomes in patients with metastatic renal cell carcinoma (RCC) receiving systemic therapy. However, none have yet examined cytokine concentrations in parallel
Externí odkaz:
https://doaj.org/article/ec3a09751cf44ea391a9bc32406367a4
Autor:
Sumanta Pal, Nazli Dizman, JoAnn Hsu, Nicholas Salgia, Milton L Greenberg, Andrew C Newman, Jonathan Skupsky, Zeynep Zengin, Luis Meza, Neal Chawla, Sabrina Salgia, Jasnoor Malhotra
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/c7db408b55554bceb3ba79d95d5e6cbf
Autor:
Sumanta Pal, Paulo Gustavo Bergerot, Nazli Dizman, JoAnn Hsu, Yung Lyou, Nicholas Salgia, Daniel Enriquez, Tyler Izatt, Jeffrey M Trent, Sara Byron
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background The clinical significance of tumor-specific genomic alterations in metastatic renal cell carcinoma (mRCC) is emerging, with several studies suggesting an association between PBRM1 mutations and response with immunotherapy (IO). We sought t
Externí odkaz:
https://doaj.org/article/3513da1694804e69aab6fb446c27e65d
Autor:
Brian J. Hansen, Jichao Zhao, Katelynn M. Helfrich, Ning Li, Alexander Iancau, Alexander M. Zolotarev, Stanislav O. Zakharkin, Anuradha Kalyanasundaram, Megan Subr, Nawshin Dastagir, Roshan Sharma, Esthela J. Artiga, Nicholas Salgia, Mustafa M. Houmsse, Omar Kahaly, Paul M. L. Janssen, Peter J. Mohler, Nahush A. Mokadam, Bryan A. Whitson, Muhammad R. Afzal, Orlando P. Simonetti, John D. Hummel, Vadim V. Fedorov
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 19 (2020)
Background Atrial fibrillation (AF) driver mechanisms are obscured to clinical multielectrode mapping approaches that provide partial, surface‐only visualization of unstable 3‐dimensional atrial conduction. We hypothesized that transient modulati
Externí odkaz:
https://doaj.org/article/8f6472004e244b198cbef26b3fa05dbc
Autor:
Zeynep B, Zengin, Ameish, Govindarajan, Nicholas, Salgia, Nicolas, Sayegh, Nishita, Tripathi, Ramya, Muddasani, Alex, Chehrazi-Raffle, Matthew, Feng, Benjamin D, Mercier, Colton, Ladbury, Claire, Hao, Sabrina, Salgia, Neal, Chawla, Luis, Meza, Jasnoor, Malhotra, Nazli, Dizman, JoAnn, Hsu, Daniela V, Castro, Regina, Barragan-Carrillo, Hedyeh, Ebrahimi, Errol J, Philip, Mark, Chang, Jiaming, Zhang, Sara, Byron, Yung, Lyou, Tanya, Dorff, Sumanta K, Pal, Savita, Dandapani
Publikováno v:
European Urology Oncology.
Stereotactic body radiation therapy (SBRT) has been shown to be safe and effective for delaying systemic treatment change among patients with metastatic renal cell carcinoma (mRCC). In this study, we sought to assess the genomic signatures of patient
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 39:338-345
In less than 5years immune checkpoint inhibitors (ICI) went from first FDA approval to become first-line options in advanced renal cell carcinoma. Despite that many patients have benefited from ICI, a significant fraction of individuals are refractor
Autor:
Paulo Gustavo Bergerot, Errol J. Philip, William Dale, Matthew Loscalzo, JoAnn Hsu, Dena Battle, Cristiane Decat Bergerot, Sumanta K. Pal, Nicholas Salgia, Megan Salgia, Ulka N. Vaishampayan, Nazli Dizman
Publikováno v:
Cancer. 127:354-358
BACKGROUND Patient-reported outcomes have been used to assess treatment effectiveness and actively engage patients in their disease management. This study was designed to describe the patient-reported performance status (PS) and the provider-reported
Autor:
Nazli Dizman, Nicholas Salgia, Paulo Gustavo Bergerot, Sumanta K. Pal, Sarah K. Highlander, Jeffrey M. Trent, Manuel Caitano Maia, John D. Gillece, Lauren Reining, Megan Folkerts, JoAnn Hsu
Publikováno v:
European Urology. 78:498-502
Preclinical models and early clinical data suggest an interplay between the gut microbiome and response to immunotherapy in solid tumors including metastatic renal cell carcinoma (mRCC). We sought to characterize the stool microbiome of mRCC patients
Publikováno v:
Kidney Cancer. 4:159-166
BACKGROUND: No study to date has assessed the relationship between treatment-specific therapeutic outcomes and race/ethnicity in metastatic renal cell carcinoma (mRCC). As targeted therapies have formed the backbone of first-line treatment options fo
Autor:
Yash Dara, Sumanta K. Pal, Matthew Feng, Nicholas Salgia, Dhruv Prajapati, Nora Ruel, Meghan Salgia, Michael Nissanoff, Richard Harwood
Publikováno v:
Kidney Cancer. 4:103-109
BACKGROUND: Twitter has emerged as an important platform for conversation surrounding cancer-related topics. As use has proliferated, a better classification of physicians engaging in cancer discussions on Twitter is warranted. OBJECTIVES: To better